UP!

COTY $7.04

COTY target price
7.04
0
0
Coty, Inc.
Type
Public
Traded as NYSE: COTY
S&P 500 Component
Industry Beauty
Founded 1904 in Paris, France
Headquarters New York City, United States
Key people
Bart Becht, Chairman
Camillo Pane, CEO
Products Fragrance
Cosmetics
Skin care
Hair care
Revenue US$9 billion (Fiscal year 2016 pro forma)
Number of employees
Over 20,000 worldwide
Website www.coty.com

Coty, Inc., is a North American beauty products manufacturer based in New York founded in Paris, France, by François Coty in 1904. Its main products are fragrances, colour cosmetics and skin and body care products. It is known for its cooperation with designers and celebrities for the creation of fragrances. Its biggest brands, or "power brands" as it calls them, are: Calvin Klein (fragrance and cosmetics), Chloe (fragrance), Davidoff (fragrance), y (fragrance), Marc Jacobs (fragrance), Philosophy (beauty), Adidas (fragrance and beauty), Playboy (fragrance), OPI Products (beauty), Rimmel London (make-up), Max Factor (cosmetics) and Sally Hansen (beauty).

In 1904, François Coty founded Coty in Paris, with a goal to revolutionize the fragrance industry. In 1912, Coty opened subsidiaries in London and New York. Coty, Inc., became a publicly traded company in 1925 and acquired a majority interest in the European Coty companies in 1929.

During the Great Depression, sales in the United States fell from US$50 million in 1929 to $3.5 million in 1933. According to The New York Times, management 'compounded its mounting problems by slashing prices in a desperate effort to gain a mass market ... a near-fatal move in a field in which prestige and the luxury symbol were vital.' With World War II imminent, the foreign companies were folded into the newly created Panama-based Coty International Corporation in 1939. The ownership remained the same, and the two corporations had interlocking directorships.

The ownership transferred from Coty to his ex-wife Yvonne, who had, by then, married Leon Cotnareanu. The management was taken over by the Cotnareanu family and passed on to Philip Cotnareanu, who changed his name to Philip Cortney, over time.

After the Great Depression, Philip secured bank financing to keep Coty going and, in one of his first decisions, raised prices for the entire line. In spite of a long-range program to double the company's retail business, he cut off drugstores carrying Coty products if they would not agree to provide display space of at least 16 feet in length for exclusive stocking of these goods. Production lines were automated, packaging restyled, and new lines of goods added periodically, including, in 1955, a new toilet-goods line for men named 'Preferred Stock'. Research laboratories were established in Morris Plains, New Jersey, and overseas.

In 1946, Coty's first postwar year, sales nearly doubled from the 1941 total, to US$19.1 million, and net profit reached $1.24 million. The company lost money in 1947, however, and, although it returned to profitability, sales stagnated. Fiscal 1955 (the year ended June 30, 1955) was Coty's best postwar year, with net income of $1.61 million on sales of $22.76 million. The firm lost money in fiscal 1957 and 1958, with management blaming the results on the high cost of advertising, which rose from 7% to 16% of sales in this period. Moreover, firms like Revlon, Inc., which reaped huge publicity from its sponsorship of television's The $64,000 Question, seemed to be getting better results for the money. In fiscal 1962, Coty had net income of only $386,985 on sales of $25.46 million. Coty International had a profit of $319,331 on sales of $7.38 million.

Coty and Coty International were sold in 1963 to Chas. Pfizer & Co. for about US$26 million and became divisions in the pharmaceuticals company's consumer products group. In 1965 Coty introduced Imprevu, its first new perfume in 25 years. This became the leading Coty fragrance by the end of 1968.

Coty and Coty International were united in 1973. Among the new products introduced in the early 1970s were the Styx, Sweet Earth, and Wild Musk fragrances and the Equatone beauty-treatment line. The production facility was moved from New York City to Sanford, North Carolina, at this time. Coty products were being marketed to franchised accounts, including distributors, independent drugstores, mass merchandisers, and department stores. Results were not meeting expectations, however, for the subsidiary was reported to be on the block in 1974 for possibly as little as $20 million—less than Pfizer had paid a decade earlier.

Coty was purchased in 1992 by Benckiser Consumer Products, the U.S. arm of a family-owned German household-products giant named Joh. A. Benckiser GmbH (now known as JAB Holding Company). In 1993 Benckiser merged into Coty its Quintessence Inc. unit, which it had acquired the previous year. Coty, Inc., grew into a US$1.5-billion-a-year company in 1996, when Benckiser made its Lancaster Group a Coty division. (The existing Coty, renamed Coty Beauty, became the other division.) Lancaster, founded in Monaco in 1946 and acquired from SmithKline Beecham plc in 1990.

During the year of 1998, 45 percent of the company's sales were in mass fragrances, 24 percent in mass cosmetics, and 31 percent in prestige-market beauty products. Fifty-five percent of sales volume came from Western Europe and 30 percent from North America.

In May 2005, Unilever announced that it had signed a definitive agreement to sell its global prestige fragrance business, Unilever Cosmetics International (UCI), to Coty, Inc., of the United States. However, several major brands were sold to Elizabeth Arden.

Unilever reportedly received a consideration of US$800 million in cash at the closing, with the opportunity for further deferred payments contingent upon future sales.

The business included the perfume licenses for Calvin Klein, Cerruti, Vera Wang, Chloé and Lagerfeld, as well as a manufacturing and distribution center in Mount Olive, New Jersey, which was later closed in June 2007 as operations were transferred to the existing Coty-Sanford, North Carolina, facility.

Sales for the global prestige fragrance business for 2004 were in excess of $600 million (€490m). In December 2007, Coty announced the acquisition of DLI Holding Corp.

The Calgon and Healing Garden brands were purchased by Ascendia Brands on 9 February 2007.

In August 2009, Coty, Inc., announced that it had entered into a license agreement with global lifestyle brand GUESS?, Inc., to develop and market new GUESS fragrance lines. As part of the partnership, Coty would also distribute existing GUESS fragrances, effective January 2010.

In November 2010, Coty, Inc., announced that Coty has entered into an agreement to acquire philosophy, inc., from the Carlyle group. In early 2011, Coty, Inc., announced that it had officially concluded the acquisitions of Dr. Scheller Cosmetics, OPI Products, Inc., and TJoy.

In July 2012, Coty, Inc., appointed Michele Scannavini as the new CEO. Scannavini has been president of Coty Prestige for the last 10 years.

On June 13, 2013, Coty, Inc., became a public company via the initial public offering of its Class A shares on the NYSE. Coty raised $1.0 billion in the largest consumer IPO since Arcos Dorados' $1.3 billion IPO in 2011. The company operates in three segments: fragrances, color cosmetics and skin and body care.

In June 2014, Coty discontinued TJoy. On September 29, 2014, Michele Scannavini had stepped down from the CEO position, and Bart Becht named interim CEO.

On July 9, 2015, Coty announced it had reached a definitive agreement to purchase some of Procter & Gamble's beauty brands for $12.5 billion in a deal that would more than double its sales and transform it into one of the world’s largest cosmetics companies.

In October 2015, Coty acquired leading global digital marketing platform Beamly, providing Coty with a step change across digital marketing capabilities

In November 2015, Coty acquired Hypermarcas’ Beauty & Personal Care Business, providing Coty a strong position in Brazilian beauty & personal care market, the third-largest beauty market in the world.

In July 2016, Coty named Camillo Pane as CEO and member of the Coty Board, each effective as of the day following the closing of the merger with P&G Specialty Beauty.

In October 2016, Coty completed its merger with P&G Specialty Beauty Business, transforming Coty into one of the world’s leading beauty companies with the number one position in fragrances, and number two and three positions in salon hair and color cosmetics, respectively.

In October 2016, the company confirmed it had reached an agreement with Lion Capital LLP to buy Good Hair Day (GHD), a manufacturer of hair care products, for $522 million in cash. GHD will be run by its existing management team. The sale was completed on 21 November 2016.

In June 2017, the company shared its branding with KFMC Trading to create a public stock profile. Thereby, KFMC Trading owns a large portion of COTY brands in the NYC STOCK EXCHANGE as well as LVMH group's official brands of YSL, and LV. Prada is still free of KFMC Trading CO. Partnering with KFMC has brought COTY an increase of 5 Billion since last years call. Estimates predict this rate to continue to rise. The sale was completed on 21 November 2016.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q1 2023 2022-11-07 Future report Set alerts
Q4 2022 2022-08-25 -0.01 -0.01
Q3 2022 2022-05-09 0.03 0.03
Q2 2022 2022-02-08 0.17 0.17
Q1 2022 2021-11-08 0.08 0.08
Q4 2021 2021-08-26 -0.09 -0.09
Q3 2021 2021-05-10 0.00 0.00
Q2 2021 2021-02-09 0.12 0.12
Q1 2021 2020-11-06 0.00 0.00
Q4 2020 2020-08-27 -0.51 -0.91

Ratings

2016-07-09 Reiterated Rating Barclays PLC Hold
2016-06-20 Reiterated Rating B. Riley Sell $19.50
2016-06-15 Reiterated Rating B. Riley Sell $19.50
2016-05-31 Reiterated Rating Deutsche Bank Buy
2016-05-31 Reiterated Rating Deutsche Bank AG Buy
2016-05-10 Reiterated Rating B. Riley Sell $19.50
2016-05-06 Reiterated Rating Piper Jaffray Neutral $30.00 to $29.00
2016-05-06 Reiterated Rating Piper Jaffray Cos. Neutral $30.00 to $29.00
2016-05-05 Lower Price Target Barclays Equal Weight $27.00 to $26.00
2016-05-05 Reiterated Rating B. Riley Sell $19.50
2016-05-05 Lower Price Target Barclays PLC Equal Weight $27.00 to $26.00
2016-05-04 Lower Price Target Stifel Nicolaus Buy $33.00 to $32.00
2016-05-04 Reiterated Rating Bank of America Hold
2016-05-04 Reiterated Rating Bank of America Corp. Hold
2016-04-30 Reiterated Rating B. Riley Sell $19.50
2016-04-25 Reiterated Rating B. Riley Sell $19.50
2016-04-18 Downgrade Bank of America Buy to Neutral $31.00
2016-04-13 Boost Price Target Stifel Nicolaus Buy $31.00 to $33.00
2016-03-28 Boost Price Target JPMorgan Chase & Co. Outperform $24.50 to $27.00
2016-02-10 Reiterated Rating B. Riley Sell $20.00
2016-02-05 Reiterated Rating Piper Jaffray Hold $31.00 to $30.00
2016-02-05 Lower Price Target B. Riley Sell $21.00 to $20.00
2016-02-04 Lower Price Target Citigroup Inc. Neutral $30.00 to $26.00
2016-01-18 Reiterated Rating B. Riley Sell $21.00
2016-01-13 Reiterated Rating B. Riley Sell $24.00 to $21.00
2015-11-30 Downgrade Morgan Stanley Equal Weight to Underweight $31.00 to $26.00
2015-11-11 Reiterated Rating B. Riley Sell $24.00
2015-11-06 Lower Price Target Deutsche Bank Buy $33.00 to $31.00
2015-11-06 Reiterated Rating B. Riley Sell $24.00
2015-11-02 Boost Price Target B. Riley Neutral $18.00 to $20.00
2015-09-01 Initiated Coverage Morgan Stanley Equal Weight $31.00
2015-08-26 Reiterated Rating JPMorgan Chase & Co. Overweight to Hold
2015-08-25 Downgrade JPMorgan Chase & Co. Overweight to Neutral $31.00
2015-08-19 Reiterated Rating B. Riley Sell $22.00
2015-08-17 Reiterated Rating Deutsche Bank Buy $33.00
2015-08-14 Reiterated Rating Piper Jaffray Hold $24.00 to $29.00
2015-08-14 Reiterated Rating B. Riley Sell $23.00 to $22.00
2015-07-21 Boost Price Target RBC Capital Sector Perform $23.00 to $30.00
2015-07-21 Boost Price Target Royal Bank Of Canada Sector Perform $23.00 to $30.00
2015-07-20 Initiated Coverage Sterne Agee CRT Neutral
2015-07-14 Reiterated Rating B. Riley Sell $23.00
2015-07-14 Reiterated Rating Deutsche Bank Buy $28.00 to $33.00
2015-07-10 Reiterated Rating Citigroup Inc. Neutral
2015-07-10 Downgrade Wells Fargo & Co. Outperform to Market Perform
2015-07-10 Reiterated Rating Piper Jaffray Neutral $24.00
2015-07-10 Downgrade Wells Fargo Outperform to Market Perform
2015-07-09 Reiterated Rating B. Riley Sell $23.00
2015-07-09 Reiterated Rating Stifel Nicolaus Buy $28.00 to $35.00
2015-06-17 Downgrade Citigroup Inc. Buy to Neutral
2015-05-11 Boost Price Target Citigroup Inc. Buy $25.00 to $29.00
2015-05-11 Reiterated Rating B. Riley Sell $19.50
2015-05-08 Boost Price Target JPMorgan Chase & Co. Overweight $24.50 to $27.00
2015-05-08 Boost Price Target Stifel Nicolaus Buy $24.00 to $28.00
2015-04-02 Downgrade BMO Capital Markets Outperform to Market Perform
2015-04-02 Reiterated Rating B. Riley Sell $18.50
2015-03-26 Downgrade B. Riley Neutral to Sell $20.00 to $18.50
2015-02-22 Reiterated Rating BTIG Research Buy $26.00
2015-02-10 Reiterated Rating B. Riley Neutral $20.00
2015-02-09 Boost Price Target Citigroup Inc. Buy $22.00 to $25.00
2015-02-06 Boost Price Target JPMorgan Chase & Co. Overweight $22.00 to $23.00
2015-01-28 Downgrade Piper Jaffray Overweight to Neutral $20.00
2015-01-22 Upgrade Citigroup Inc. Neutral to Buy $22.00
2015-01-15 Reiterated Rating Deutsche Bank Buy $20.00 to $23.00
2015-01-12 Boost Price Target JPMorgan Chase & Co. Overweight $20.00 to $22.00
2014-12-16 Boost Price Target Wunderlich Outperform $20.00 to $22.00
2014-12-15 Initiated Coverage KeyBanc Hold
2014-12-15 Initiated Coverage KeyCorp Hold
2014-12-12 Boost Price Target Bank of America Buy $20.00 to $22.00
2014-11-19 Initiated Coverage BTIG Research Buy $23.00
2014-11-10 Boost Price Target B. Riley Neutral $14.00 to $18.00
2014-11-07 Reiterated Rating Citigroup Inc. Neutral $18.00 to $19.00
2014-10-31 Upgrade Stifel Nicolaus Hold to Buy $20.00
2014-10-08 Upgrade B. Riley & Co. Sell to Neutral $14 to $14
2014-10-08 Upgrade B. Riley Sell to Neutral $14.00
2014-09-22 Reiterated Rating JPMorgan Chase & Co. Overweight $18.50 to $20.00
2014-09-19 Downgrade B. Riley & Co. Neutral to Sell
2014-09-19 Downgrade B. Riley Neutral to Sell $14.00
2014-09-18 Initiated Coverage Piper Jaffray Overweight $20.00
2014-09-02 Boost Price Target Citigroup Inc. Neutral $16.00 to $18.00
2014-08-29 Reiterated B. Riley & Co. Neutral $16 to $14
2014-08-29 Lower Price Target Credit Suisse Neutral $19.00 to $18.00
2014-08-29 Lower Price Target B. Riley Neutral $16.00 to $14.00
2014-08-29 Lower Price Target Credit Suisse Group AG Neutral $19.00 to $18.00
2014-07-16 Reiterated Rating Deutsche Bank Buy $18.00 to $20.00
2014-06-30 Initiated Coverage BMO Capital Markets Outperform $19.00
2014-05-15 Reiterated Rating Morgan Stanley Equal Weight
2014-05-15 Boost Price Target JPMorgan Chase & Co. Overweight $16.00 to $17.00
2014-05-15 Boost Price Target Credit Suisse Neutral $15.00 to $17.00
2014-03-12 Reiterated Rating Bank of America Buy $16.00 to $17.00
2014-02-18 Lower Price Target Barclays Equal Weight $16.00 to $14.00
2014-02-06 Upgrade Wells Fargo & Co. Market Perform to Outperform
2014-02-06 Upgrade Wells Fargo Market Perform to Outperform
2014-01-07 Initiated Coverage RBC Capital Sector Perform $16.00
2013-11-19 Initiated Coverage Credit Suisse Neutral $17.00
2013-11-08 Lower Price Target JPMorgan Chase & Co. Overweight $20.00 to $18.00
2013-10-15 Initiated Coverage Barclays Equal Weight $17.00
2013-09-19 Lower Price Target B. Riley Neutral $19.00 to $17.00
2013-09-18 Reiterated Rating Citigroup Inc. Neutral $17.00
2013-09-18 Reiterated Rating Deutsche Bank Buy $20.00 to $19.00
2016-07-09 Reiterated Rating Barclays PLC Hold
2016-06-20 Reiterated Rating B. Riley Sell $19.50
2016-06-15 Reiterated Rating B. Riley Sell $19.50
2016-05-31 Reiterated Rating Deutsche Bank Buy
2016-05-31 Reiterated Rating Deutsche Bank AG Buy

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
JAB Cosmetics B.V. 334.17%  (290108041) COTY /
HEILBRONN CHARLES 16.77%  (14562993) COTY / ULTA /
HARF PETER 4.54%  (3943219) COTY /
Becht Lambertus J.H. 1.21%  (1049186) COTY /
Schoewel Erhard 0.43%  (371473) COTY /
Pane Camillo EVP Category Development 0.39%  (336142) COTY /
BLOOM BRADLEY M 0.34%  (297836) COTY /
Semerari Renato President of Coty Beauty 0.30%  (259091) COTY /
Kleitman Laurent President Coty Consumer Beauty 0.27%  (232000) COTY /
Kaufman Jules SVP General Counsel, Secretary 0.26%  (228178) COTY / IT /
Mortier Jean President of Coty Prestige 0.26%  (227705) COTY /
Faber Joachim 0.25%  (213068) COTY /
Lacassagne Geraud-Marie SVP of Human Resources 0.21%  (183718) COTY /
Monaco Kevin SVP, Treasurer & IR 0.20%  (176414) COTY /
HUBER EDGAR O. President of Coty Luxury 0.19%  (163570) COTY / LE /
McMullen Greerson Greene Chief Legal Officer 0.19%  (161725) COTY / SWM /
McCall Darryl EVP, Operations 0.19%  (160720) COTY /
Singer Robert S 0.16%  (140000) COTY / MJN /
Reis Mario EVP, Supply Chain 0.16%  (136000) COTY /
Shaefer Peter SVP, Strat. Business Developme 0.15%  (132213) COTY /
de Talhouet Patrice Chief Financial Officer 0.14%  (117206) COTY /
Froidefond Sebastien SVP of Human Resources 0.11%  (98358) COTY /
Moreau Sylvie President, Professional Beauty 0.11%  (97035) COTY /
Ramos Daniel E Chief Scientific Officer 0.08%  (69815) COTY /
STAHL JACK L 0.07%  (62685) COTY / CTLT / DPS /
Macchio Ralph SVP Global Research & Dev.,CSO 0.07%  (59352) COTY /
Zafar Ayesha SVP Group Controller 0.02%  (21570) COTY /
Muench Thomas SVP, Group Controller 0.02%  (19624) COTY /
Pedreiro Sergio Chief Financial Officer 0.02%  (19600) COTY /
Goudet Olivier 0.02%  (15000) COTY /
Shiah James E. SVP, Chief Acct. & Compl. Off. 0.01%  (11957) COTY / MJN /